Navigation Links
GenSpera G-202 data in journal
Date:6/29/2012

GenSpera, Inc. (OTCBB:GNSZ) announced that a study titled, "Engineering the Plant Product Thapsigargin into a PSMA-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy," was published in the journal, Science Translational Medicine, on June 27, 2012 (http://stm.sciencemag.org/content/4/140/140ra86). The manuscript documents the extensive pre-clinical data and rationale for the development of G-202 as a potential treatment for a variety of solid tumors in human patients.

The paper also validated the enzyme, PSMA, as an appropriate molecular target for G-202. PSMA is expressed by both prostate cancer cells and endothelial (vascular) cells in a variety of cancers, but not by most normal tissues. Finally, the paper showed G-202 toxicity to be low in animal models. Based on these results, the researchers concluded that the G-202 cytotoxin and prodrug delivery platform produced sufficient therapeutic results to support advancing G-202 to human clinical trials.

"This publication marks the culmination of 40 years of collaborative, interdisciplinary research," said Sren Brgger Christensen, PhD, study author, Professor at the University of Copenhagen and a member of GenSpera's Scientific Advisory Board. "We began studying the medicinal properties of the plant, Thapsia garganica, in the 1970's. Our group was the first to isolate the active ingredient, thapsigargin, elucidate its chemical structure and demonstrate that it kills tumor cells by blocking a specific intracellular calcium pump. Thapsigargin kills cells independently of their rate of cell division, which we believe can make it more effective than standard chemotherapeutic agents in treating a wide variety of human tumors."

"This paper represents a rare 'brain-to-bench-to-bedside' translational story," said John Isaacs, PhD, study author, Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center
'/>"/>

Contact: Deanne Eagle
deanneeagle@gmail.com
917-837-5866
Planet Communications
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Ear, Nose & Throat Journal publishes research on breakthrough treatment for tonsil stones
2. Anti-cocaine vaccine described in Human Gene Therapy Journal
3. New England Journal of Medicine hails new skin cancer drug as greatest advance yet
4. Elsevier, SVS announce 2013 launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders
5. NAMS journal Menopause reflects on the WHI 10 years later
6. Reactions to HIV drug have autoimmune cause, reports AIDS journal
7. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
8. Journals and pharma collaborate on new recommendations
9. Model for breast cancer rehab featured in supplement to ACS journal, Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 06, 2015 Inversion Studios, ... in yoga and Pilates classes, provides personalized individual ... products, starting with its new Pilates Ring magic ... of becoming leaner, stronger, more centered and graceful, ... a fresh venue to healthy fitness through yoga ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Vancouver ... recently shared their new blog containing the Canadian ... by the Canadian Society for Exercise Physiology (CSEP). ... physical activity, health and fitness research and personal ... and exercise are highly beneficial and a rich ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Anitoa Systems, ... partnering with Zhejiang University of China, has successfully demonstrated ... ultra-low-light CMOS bio-optical sensor. Anitoa’s handheld qPCR is ... pathogen DNA and RNA’s, including hepatitis B, C, and ... of 4 copies per sample and over 9 orders ...
(Date:5/6/2015)... TU-Automotive has opened press registration for TU-Automotive Detroit as ... the headlines of major publications world-wide. With 150+ speakers ... ready to share their visions for the future of ... press to go behind the scenes and hear major ... “This year we’re releasing a preview of all the ...
(Date:5/6/2015)... WASHINGTON, DC (PRWEB) May 06, 2015 ... international organization representing the regenerative medicine and advanced ... first-ever quarterly data report, offering an in-depth look ... January through March 2015. , The report is ... standalone graphics highlighting key data points, available ...
Breaking Medicine News(10 mins):Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3Health News:Press Registration for TU-Automotive Detroit Now Open 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... The Environment and Health & Beauty Get a ... 3 HowToDoThings.com, a,popular online destination that helps ... instruction on diverse topics, celebrates the,world,s most popular ... coffee, in recognition of "Caffeine Awareness Month" in ...
... American Cancer Society, (http://www.cancer.org ) lists March 2008 ... the onset of colon cancer. According to the ... cases are discovered,annually...deaths from Colon and Rectal Cancer ... either avoid Colon Cancer or detect,tumors earlier than ...
... Scotland, March 3 Aircraft Medical, the UK,medical ... sponsoring the,prestigious 14th World Congress of Anaesthesiologists (the ... Draeger. Held every four,years, the WCA is the ... is Aircraft Medical sponsoring the event, but the ...
... same doctor during their first six months of life ... -- for lead poisoning, anemia and tuberculosis -- by ... by the same physician, often referred to as continuity ... children they studied. , Researchers from The Children,s Hospital ...
... Corporation of,North America, its U.S. subsidiary, MGI PHARMA, ... U.S. Food and Drug Administration,(FDA) has approved Aloxi(R) ... and vomiting (PONV) for up to 24 hours,following ... demonstrated., Aloxi, available in the United States ...
... cells may provide an explanation for the cause of ... causes premature aging in children, according to researchers at ... Institutes of Health (NIH). These findings, the first ... of HGPS, also known as progeria, may also provide ...
Cached Medicine News:Health News:HowToDoThings.com Brews Up New Uses for Coffee That Will Perk You Up in Recognition of March's 'Caffeine Awareness Month' 2Health News:SGV Medical Supplies: 'Colostomy Supplies Easier to Obtain for the Colon Cancer Survivor' 2Health News:Aircraft Medical to Sponsor World's Premier Anaesthesiology Conference 2Health News:In early childhood, continuous care by 1 doctor improves delivery of health screenings 2Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 2Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 3Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 4Health News:FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting 5Health News:Adult stem cell changes underlie rare genetic disease associated with accelerated aging 2
(Date:5/6/2015)... May 06, 2015 Research and Markets ... of the "Global Insulin Patch Market Opportunity ... Highly advanced technology like ultrasound and iontophoresis are ... patches. Depending upon the type of technique, their ... reach of several patients. In long-term, it would ...
(Date:5/6/2015)... --  CEFALY Technology , the creators of the first ... use prior to the onset of migraine pain, is ... the EUROHEADPAIN - Midterm Meeting at the International Headache ... from May 14-17, 2015. On May 14 ... European research project focused on migraines, CEFALY Technology ...
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
Breaking Medicine Technology:Global Insulin Patch Market Opportunity Analysis 2015 2CEFALY to Present Breakthrough Data in Migraine Treatment at International Headache Society Congress 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2
... importance of electronic connectivity for ... understood. Transmission of patient results ... records, and billing. A sound ... connectivity is essential to ensure ...
248 is fully automated blood gas systems offering a cost-effective solution for critical care testing in settings with low to medium workloads....
... Discovery 90SE Ultracentrifuge offers ... discover more. All the ... top-of-the-line performance, powerful functionality, ... use, all built into ...
... g-force ever. But optimal productivity in the ... combines maximum force, capacity, and ease of ... apart from any other system. With advanced ... Optima takes productivity to the MAX. Optima ...
Medicine Products: